Capital Research Global Investors
ISRG icon

Capital Research Global Investors’s Intuitive Surgical ISRG Stock Holding History

Capital Research Global Investors’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446M Sell
966,639
-197,098
-17% -$99.7M 0.07% 178
2025
Q4 		$659M Sell
1,163,737
-388,935
-25% -$207M 0.12% 128
2025
Q3 		$694M Sell
1,552,672
-1,302,661
-46% -$625M 0.13% 124
2025
Q2 		$1.55B Sell
2,855,333
-509,836
-15% -$267M 0.31% 74
2025
Q1 		$1.67B Sell
3,365,169
-16,133
-0.5% -$8.92M 0.36% 66
2024
Q4 		$1.76B Buy
3,381,302
+687,906
+26% +$358M 0.36% 65
2024
Q3 		$1.32B Buy
2,693,396
+443,727
+20% +$207M 0.28% 79
2024
Q2 		$1B Buy
2,249,669
+1,311,560
+140% +$522M 0.22% 93
2024
Q1 		$374M Buy
+938,109
New +$354M 0.08% 169
2013
Q4 		– Sell
-1,350,000
Closed -$56.4M – 441
2013
Q3 		$56.4M Buy
+1,350,000
New +$59.6M 0.02% 321

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors's ISRG Position: Q1 2026 in Review

Capital Research Global Investors reduced its Intuitive Surgical (ISRG) stake by 17% in Q1 2026, selling an estimated $99.7M and leaving 966,639 shares worth $446M. The position accounts for 0.07% of the portfolio, ranked #178.

Capital Research Global Investors first reported a position in ISRG in Q3 2013 and has held it in 10 quarters since. The position peaked at $1.76B in Q4 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Capital Research Global Investors held 966,639 shares of Intuitive Surgical worth $446M as of Q1 2026.
  • Capital Research Global Investors sold 197,098 Intuitive Surgical shares in Q1 2026, an estimated $99.7M.
  • Intuitive Surgical made up 0.07% of Capital Research Global Investors's portfolio in Q1 2026, its #178 holding.
  • Capital Research Global Investors first reported a position in Intuitive Surgical in Q3 2013 and has held it in 10 quarters since.
  • Capital Research Global Investors's Intuitive Surgical position peaked at $1.76B in Q4 2024.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.